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Summary diseases associated with cholestasis, gGT is released into
the circulation, from the canalicular membrane, by the
Progressive familial intrahepatic cholestasis (PFIC; detergent effects of bile acids. Benign recurrent intrahe-
OMIM 211600) is the second most common familial patic cholestasis (BRIC; OMIM 243300) is a phenotype
cholestatic syndrome presenting in infancy. A locus has similar to PFIC, with a relapsing course but no progres-
previously been mapped to chromosome 18q21-22 in sive derangement of liver function and in which, be-
the original Byler pedigree. This chromosomal region tween attacks, the biochemical parameters return to nor-
also harbors the locus for benign recurrent intrahepatic mal.
cholestasis (BRIC) a related phenotype. Linkage analysis Recent linkage studies have demonstrated that the ge-
in six consanguineous PFIC pedigrees from the Middle netic heterogeneity underlying these diseases does not
East has previously excluded linkage to chromosome correspond to the existing phenotypic or eponymous
18q21-22, indicating the existence of locus heterogene- classiﬁcation. A locus for BRIC was mapped to chromo-
ity within the PFIC phenotype. By use of homozygosity some 18q21-22 by detection of a shared haplotype in
mapping and a genome scan in these pedigrees, a locus an inbred Dutch population (Houwen et al. 1994). A
designated ‘‘PFIC2’’ has been mapped to chromosome locus for PFIC (PFIC1) was subsequently mapped to the
2q24. A maximum LOD score of 8.5 was obtained in same region by detection of a preserved haplotype in
the interval between marker loci D2S306 and D2S124, affected members of the original Byler pedigree, sug-
with all families linked. gesting that the two phenotypes are allelic variants
(Carlton et al. 1995). However, analysis of three sepa-
rately ascertained groups of families segregating a simi-Introduction
lar clinical phenotype, including the group from the
The designation ‘‘progressive familial intrahepatic cho- Middle East that was analyzed in the present study,
lestasis’’ (PFIC) has been used in a broad, descriptive excluded linkage to the region on chromosome 18 (An-
sense to encompass a number of inherited disorders in neren et al. 1996; Strautnieks et al. 1996; Bull et al.
which there is failure of bile production or excretion and 1997). These observations indicated the existence of lo-
a progressive clinical course in the absence of evidence of cus heterogeneity.
a primary hepatitis. It is also used more speciﬁcally to A genomewide search was therefore undertaken in a
refer to a disease ﬁrst described in an Old Order Amish group of six consanguineous families of Middle Eastern
pedigree descended from a Jacob Byler (Clayton et al. origin, using homozygosity mapping. Evidence was ob-
1965). This variety of PFIC is sometimes referred to as tained for a second locus on chromosome 2, designated
‘‘Byler disease’’ (OMIM 211600) or, in patients with ‘‘PFIC2.’’
similar features but no Amish ancestry, as ‘‘Byler syn-
drome’’ (Riely 1994). Its biochemical hallmark is the Subjects and Methods
presence of normal levels of both serum cholesterol and
Patients and Familiesplasma g-glutamyl transpeptidase (gGT) (Whitington et
al. 1994). This is a distinctive feature, since, in most The six pedigrees included in this study are shown in
ﬁgure 1. All families are consanguineous, the parents
being ﬁrst cousins in each case. The families are not
known to be interrelated. Families 1–5 are as numberedReceived February 6, 1997; accepted for publication June 11, 1997.
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Figure 1 Pedigrees and allele data of PFIC families. Consanguineous marriages are all between ﬁrst cousins. Allele sizes for the marker
loci used are shown under each individual available for marker typing. The numbers are alleles of each individual at each locus and correspond
to the allele numbers used in the Genome Database. Genotypes unavailable are depicted as dual pairs of dashes (-- --). The regions of
homozygosity in the affected individuals are gray shaded. The limiting recombinations are conﬁrmed by other markers not shown. The relative
positions of loci are based on a number of published maps (Collins et al. 1996; Dib et al. 1996).
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DNA Analysis/Marker Typing disease and D2S124 in families 2 and 5 (ﬁg. 1). These
two markers are 2 cM apart. A multipoint LOD scoreGenomic DNAwas extracted fromwhite cells by stan-
was calculated by use of allele data from 22 markerdard methods. DNA was ampliﬁed by PCR using ﬂuo-
loci from the interval between D2S151 and D2S326.rescently labeled primers or dUTPs (Applied Biosys-
A maximum value of 8.5 was obtained in the intervaltems). The marker loci were selected from published
between D2S306 and D2S124, with a Å 1.genetic maps. Primers for a set of 200 polymorphic
marker loci were supplied by the Human Genome Map-
ping Project UK. Primer sequences are available from Discussion
the Genome Database (GDB).
A second PFIC locus has beenmapped to chromosomePCR was performed in 96-well microtiter plates (Hy-
2q24 and has been designated ‘‘PFIC2.’’ The locus het-baid). Each well contained 20–50 ng of genomic DNA;
erogeneity, between Byler disease and these families, has1.5 mM MgCl2; 1 1 reaction buffer (Advanced Biotech-
some phenotypic correlations. The striking granular ap-nologies); 200 mM each of dGTP, dATP, dTTP, and
pearance of the ‘‘Byler bile’’ seen on electron microscopydCTP; 50 ng of each primer, and 0.2 U of Red Hot
is absent in these Middle Eastern patients (Bull et al., inDNA polymerase (Advanced Biotechnologies), in a total
press). Second, they lack the relapsing course seen in thevolume of 15 ml. Thirty cycles were performed in a ther-
early stages of Byler disease and instead have a moremocycler (Hybaid OmnigeneTM). Alleles were separated
continuous progression. This is of particular interest,on a 6% polyacrylamide electrophoresis gel for 3–4 h
since it is a feature common to Byler disease and BRIC,at a rate-limiting voltage of 1,100 V, with a model 373A
which are probably allelic variants.DNA sequencer (Applied Biosystems). Analysis of the
The genetic region within which PFIC2 must lie is aallele sizes was performed by GENESCANTM672 (ver-
2-cM length of chromosome 2q and is deﬁned by thesion 1.2) and Genotyper softwares (Applied Biosys-
limiting recombinations at D2S306 and D2S124.tems), by use of GENESCANTM-500 TAMRA or GEN-
Within this region there is no evidence, so far, of allelicESCANTM-2500 ROX as size standards.
association. Although the families used in this study are
Linkage Analysis not known to be interrelated, it can be anticipated that
there has been a founder effect within this population.Linkage analysis was performed under the assumption
The absence of apparent linkage disequilibrium is prob-of fully penetrant autosomal recessive inheritance with
ably a reﬂection of the marker density and of the lacka disease-allele frequency of .001. Multipoint analysis
of rare alleles in the affected individuals.was performed by use of the GENEHUNTER program
The biochemical features of Byler disease and these(Kruglyak et al. 1996). The marker loci from chromo-
patients suggest a defect in the transport of bile acidssome 2 that were included in this analysis were D2S151,
from blood to bile. Bile acids are synthesized de novoD2S356, D2S2299, D2S321, D2S141, D2S142,
by hepatocytes but are also subject to an efﬁcient entero-D2S2360, D2S284, D2S1353, D2S2190, D2S2370,
hepatic circulation. Ninety percent of the bile-acid con-D2S156, D2S306, D2S2380, D2S354, D2S124,
tent of bile is reabsorbed in the small intestine via atD2S111, D2S382, D2S399, D2S2345, D2S335 and
least one speciﬁc transporter (Wong et al. 1996) andD2S326. Allele frequencies were obtained from GDB,
enters the portal circulation. In normal individuals, up-with frequencies restricted to §.10. Homogeneity test-
take of bile acids by hepatocytes achieves a ﬁrst-passing was performed within GENEHUNTER.
clearance of 80%–90%. As a result, total serum bile
acids are normally maintained at õ10 mmol/liter in pe-Results
ripheral blood. To achieve this, there is at least one
highly efﬁcient bile-acid transporter on the basolateralAn initial screen of 342 marker loci revealed 10 re-
gions at which affected individuals in at least three fami- surface of hepatocytes (Hagenbuch et al. 1991). It is
assumed that cytoskeletal elements are involved in trans-lies showed homozygosity. Additional loci were there-
fore typed in and on either side of these regions. These cytotic movement of bile acids (Frimmer and Ziegler
1988) and that there are multiple, quite distinct trans-additional data demonstrated that the region on chro-
mosome 2 alone was homozygous by descent, in all the porters on the canalicular surface (Inoue et al. 1984).
There are therefore a number of sites at which hepaticaffected individuals.
On chromosome 2, regions of homozygosity that were bile-acid transport could fail: basolateral membrane, in-
tracellular transporters, or canalicular membrane. The3–89 cM in length were identiﬁed in all affected individ-
uals. A common region of homozygosity was present in severity of the liver disease in PFIC suggests an intracel-
lular accumulation of bile acids. In contrast, a failure ofthe interval encompassed by D2S2380 and D2S354.
This interval has a minimum genetic length of 2 cM. uptake at the basolateral membrane would be unlikely
to lead to this degree of liver disease and cirrhosis, mak-Flanking recombinations were detected between the dis-
ease locus and D2S306 in family 2 and between the ing this an implausible site for the defects responsible
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Bull LN, Carlton VEH, Stricker NL, Baharloo S, DeYoungfor this type of PFIC. Therefore, the canalicular mem-
JA, Freimer NB, Magid MS, et al (1997) Genetic and mor-brane or the cytoskeleton would seem to be the most
phologic ﬁndings in progressive familial intrahepatic chole-likely candidates for the site of the defect. Transmission
stasis (Byler disease and Byler syndrome): evidence for heter-electronmicroscopy of PFIC liver biopsies shows peri-
ogeneity. Hepatology 26:155–164canalicular microﬁlamental condensation as seen in
Carlton VE, Knisely AS, Freimer NB (1995) Mapping of a
phalloidin administration (Bull et al., in press). It has locus for progressive familial intrahepatic cholestasis (Byler
been suggested that some forms of cholestasis may be disease) to 18q21-q22, the benign recurrent intrahepatic
due to abnormalities of the cytoskeleton (Weber et al. cholestasis region. Hum Mol Genet 4:1049–1053
1981). However, similar changes have been noted in Clayton RJ, Iber FL, Ruebner BH, McKusick VA (1965) By-
extrahepatic biliary obstruction (Adler et al. 1980). This ler’s disease: fatal familial intrahepatic cholestasis in an
may therefore be a secondary and nonspeciﬁc effect of Amish kindred. J Pediatr 67:1025–1028
Collins A, Frezal J, Teague J, Morton NE (1996) A metriccholestasis. It is therefore anticipated that the site of
map of humans: 23,500 loci in 850 bands. Proc Natl Acadthe defect in these patients will be at the canalicular
Sci USA 93:14771–14775membrane.
Dib C, Faure´ S, Fizames C, Samson D, Drouot N, Vignal A,These new data identify the second locus capable of
Millasseau P, et al (1996) A comprehensive genetic map ofcausing critical disruption of bile-acid transport. The
the human genome based on 5,264 microsatellites. Natureregion is still genetically large (2 cM), and the corre-
380:152–154
sponding physical distance is Ç2 Mb. There are, how- Frimmer M, Ziegler K (1988) The transport of bile acids in
ever, 20 expressed sequence tags (ESTs) already mapped liver cells. Biochim Biophys Acta 947:75–99
to this region, most with no signiﬁcant homology. Re- Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ
ﬁnement of the localization of the PFIC2 gene therefore (1991) Functional expression cloning and characterization
will be required before detection and analysis of candi- of the hepatocyte Na//bile acid cotransport system. Proc
Natl Acad Sci USA 88:10629–10633date genes. This will involve both the use of further
Houwen RH, Baharloo S, Blankenship K, Raeymaekers P,markers, in an attempt to detect linkage disequilibrium,
Juyn J, Sandkuijl LA, Freimer NB (1994) Genome screeningand analysis of other PFIC populations, to ﬁnd limiting
by searching for shared segments: mapping a gene for benignrecombinations closer to the gene. Cloning of the genes
recurrent intrahepatic cholestasis. Nat Genet 8:380–386underlying PFIC will greatly increase our knowledge of
Inoue M, Kinne R, Tran T, Arias IM (1984) Taurocholatenormal bile-acid transport mechanisms within the liver
transport by rat liver canalicular membrane vesicles: evi-
and will shed light on mechanisms of cholestasis that dence for the presence of an Na/-independent transport
may lead to new forms of treatment. system. J Clin Invest 73:659–663
Kagalwalla AF, Al-Amir AR, Khalifa A, Sylven M, Al-Ajaji
S, Kagalwalla YA (1995) Progressive familial intrahepaticAcknowledgments
cholestasis (Byler’s disease) in Arab children. Ann Trop Pae-
This study was made possible by the cooperation of patients, diatr 15:321–327
their families, and referring physicians. R.J.T. is a Wellcome Kruglyak L, DalyMJ, Reeve-DalyMP, Lander ES (1996) Para-
Trust Medical Graduate Training Fellow. A.S.K. was sup- metric and nonparametric linkage analysis: a uniﬁed
ported by a grant from the Research Advisory Committee of multipoint approach. Am J Hum Genet 58:1347–1363
the Children’s Hospital of Pittsburgh. This work was also Riely CA (1994) In: Suchy F (ed) Liver disease in children.
supported by National Institutes of Health R01 grant Mosby, St Louis, pp 451–453
DK50697 to N.F. L.B. was supported by a postdoctoral Na- Strautnieks SS, Kagalwalla AF, Tanner MS, Gardiner RM,
tional Research Service Award from the National Institutes of Thompson RJ (1996) Locus heterogeneity in progressive
Mental Health and by a Young Investigator Award from the familial intrahepatic cholestasis. J Med Genet 33:833–836
National Alliance for Research on Schizophrenia and Depres- Weber AM, Tuchweber B, Yousef I, Brochu P, Turgeon C,
sion. Gabbiani G, Morin CL, et al (1981) Severe familial cholesta-
sis in North American Indian children: a clinical model of
microﬁlament dysfunction? Gastroenterology 81:653–662References
Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ,
Sharp HL (1994) Clinical and biochemical ﬁndings in pro-Adler M, Chung KW, Schaffner F (1980) Pericanalicular hepa-
gressive familial intrahepatic cholestasis. J Pediatr Gas-tocytic and bile ductular microﬁlaments in cholestasis in
troenterol Nutr 18:134–141man. Am J Pathol 98:603–616
Wong MH, Rao PN, Pettenati MJ, Dawson PA (1996) Local-Anneren G, Nemeth A, Arnell H, Dahl N (1996) Byler disease:
ization of the ileal sodium-bile acid cotransporter geneevidence for genetic heterogeneity by exclusion of linkage
(SLC10A2) to human chromosome 13q33. Genomics 33:to the 18q21-q22 region in eight Swedish families. Eur J
Hum Genet 4 Suppl 1:99 538–540
/ 9a35$$se07 08-28-97 18:50:25 ajhgal UC-AJHG
